Argenx
ARGX
#580
Rank
โ‚น2.977 T
Marketcap
โ‚น49,786
Share price
-0.35%
Change (1 day)
22.11%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: โ‚น2.977 Trillion

As of November 2024 Argenx has a market cap of โ‚น2.977 Trillion. This makes Argenx the world's 580th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2024

End of year Market Cap

Year Marketcap Change
2024โ‚น2.977 T58.46%
2023โ‚น1.878 T8.32%
2022โ‚น1.734 T26.7%
2021โ‚น1.368 T33.48%
2020โ‚น1.025 T109.06%
2019โ‚น490.51 B100.08%
2018โ‚น245.15 B91.51%
2017โ‚น128.01 B
2014โ‚น9.22 B

End of Day market cap according to different sources

On Nov 20th, 2024 the market cap of Argenx was reported to be:

โ‚น2.987 Trillion
by Yahoo Finance info icon info icon
โ‚น2.987 Trillion
by CompaniesMarketCap info icon info icon
โ‚น2.957 Trillion
by Nasdaq info icon info icon